vitreous opacity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-60 years old, initial onset of disease duration =1 day, =6 months, patients reported obvious floaters symptoms, no obvious retinopathy 2. B-ultrasound examination revealed a significant vitreous opacity, consistent with a physiological floater diagnosis 3. Clear refractive stroma with the exception of the vitreous, no corneal and lens opacity 4. Positive treatment attitude, understanding of the purpose of the trial, voluntary participation and signing of informed consent, and ability to complete all experimental follow-up
Exclusion criteria
Exclusion criteria: 1. Pathological vitreous opacity, including vitreous hemorrhage, stellate vitreous degeneration, intraocular malignant tumors, uveitis, retinal detachment, etc. 2. Accompanied by obvious flashy sense; 3. Peripheral vitreoretinal traction or macular vitreous traction; 4. Appear with retinopathy, such as peripheral degeneration, retinal stage; 5. People with diabetes; 6. The history of intraocular drug injection; 7. History of vitreoretinal surgery; 8. History of intraocular laser therapy; 9. The history of ocular trauma; 10. The history of gastrointestinal disease; 11. History of drugs and food allergies; 12. Moderately severe depression, anxiety and other mental illnesses; 13. Don't insist on the visitor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of vitreous opacity was quantified by B-ultrasound;Score of floaters symptoms;Visual quality rating scale;Psychological anxiety score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Uncorrected visual acuity;Intraocular pressure;Fundus panoramic color photography;optical coherence tomography(OCT); | — |
Countries
China
Contacts
Hangzhou Xihu Eye Hospital at Zhijiang